Healthcare - Biotechnology - NASDAQ - US
$ 25.7
1.3 %
$ 15.1 B
Market Cap
10.12
P/E
Price Target
Average
75.10%
Revenue Forecast
Estimate
17.43%
EBIT
Estimate
19.99%
Net Income
Estimate
38.47%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Royalty Pharma plc
Wall Street analysts predict an average 1-year price target for RPRX of $45 , with forecasts ranging from a low of $28 to a high of $51 .
RPRX Lowest Price Target
Wall Street Target
28 USD
8.95%
RPRX Average Price Target
Wall Street Target
45 USD
75.10%
RPRX Highest Price Target
Wall Street Target
51 USD
98.44%
REVENUE FORECAST
Revenue Forecast Chart RPRX
EBIT FORECAST
EBIT Forecast Chart RPRX
NET INCOME FORECAST
Net Income Chart RPRX